Pulmonx
LUNG
114 hedge funds and large institutions have $1.03B invested in Pulmonx in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 35 reducing their positions, and 23 closing their positions.
572% more call options, than puts
Call options by funds: $22.4M | Put options by funds: $3.33M
23% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 35
0.86% more ownership
Funds ownership: 86.13% → 86.99% (+0.86%)
5% less funds holding
Funds holding: 120 → 114 (-6)
10% less capital invested
Capital invested by funds: $1.14B → $1.03B (-$109M)
17% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 23
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
+$72M |
| 2 |
PA
Perceptive Advisors
New York
|
+$27.8M |
| 3 |
BNP Paribas Asset Management
Paris,
France
|
+$20.3M |
| 4 |
DM
Deerfield Management
New York
|
+$12.3M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$10.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$36.2M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.3M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$13.2M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.8M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$9.63M |
LUNG Hedge Fund Activity: Q4 2021 in Review
114 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q4 2021, worth a combined $1.03B — down 9.6% from $1.14B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of LUNG and 19 opened new positions — a net loss of 4 holders — while 35 trimmed existing stakes and 43 added.
The largest buyer was Primecap Management, adding an estimated $72M. The largest seller was Gilder Gagnon Howe & Co, exiting entirely with an estimated $36.2M sold.
- 114 institutional investors held Pulmonx (LUNG) as of Q4 2021, down from 120 in Q3 2021.
- Funds reported $1.03B of Pulmonx stock for Q4 2021, down 9.6% quarter-over-quarter.
- 19 funds opened new Pulmonx positions in Q4 2021 and 23 closed out, a net change of -4 holders.
- The largest Pulmonx buyer in Q4 2021 was Primecap Management, an estimated $72M added.
- The largest Pulmonx seller in Q4 2021 was Gilder Gagnon Howe & Co, an estimated $36.2M sold.
Based on aggregated 13F filings for Q4 2021.